|
JPS6045180B2
(ja)
|
1977-05-17 |
1985-10-08 |
第一製薬株式会社 |
２−アミノテトラリン誘導体
|
|
ZA903906B
(en)
*
|
1989-05-25 |
1992-02-26 |
Takeda Chemical Industries Ltd |
Benzocycloalkane derivatives and production thereof
|
|
AU632809B2
(en)
*
|
1989-05-25 |
1993-01-14 |
Takeda Chemical Industries Ltd. |
Benzocycloalkane benzopyran and benzothiopyran urea derivatives and production thereof
|
|
FR2691145A1
(fr)
*
|
1992-05-18 |
1993-11-19 |
Inst Nat Sante Rech Med |
Nouveaux dérivés de la dihydroxybenzylamine, leur préparation et les compositions pharmaceutiques qui les contiennent.
|
|
US5807897A
(en)
|
1996-03-01 |
1998-09-15 |
Zeneca Limited |
Aminotetralin derivative and compositions and method of use thereof
|
|
US6225352B1
(en)
|
1996-08-14 |
2001-05-01 |
Warner-Lambert Company |
Low molecular weight dendritic compounds as pharmaceutical agents
|
|
NZ510988A
(en)
|
1998-10-07 |
2005-01-28 |
Ortho Mcneil Pharm Inc |
N-aralkylaminotetralins useful as ligands for the neuropeptide Y5 receptor
|
|
HUP0202143A3
(en)
|
1999-07-28 |
2003-12-29 |
Ortho Mcneil Pharm Inc |
Amine and amide derivatives as ligands for the neuropeptide y y5 receptor pharmaceutical compositions containing them and their use
|
|
DE10007948A1
(de)
|
2000-02-22 |
2001-09-06 |
Wella Ag |
Mittel zur Färbung von Fasern
|
|
FR2809396B1
(fr)
|
2000-05-24 |
2005-10-14 |
Centre Nat Rech Scient |
Nouvelles molecules possedant une activite calcimimetique et leur mode de preparation
|
|
ES2566056T3
(es)
|
2001-03-29 |
2016-04-08 |
Eli Lilly And Company |
N-(2-ariletil)bencilaminas como antagonistas del receptor 5-HT6
|
|
US20050152858A1
(en)
|
2003-07-11 |
2005-07-14 |
Isp Investments Inc. |
Solubilizing agents for active or functional organic compounds
|
|
US20070196395A1
(en)
|
2003-12-12 |
2007-08-23 |
Mackerell Alexander |
Immunomodulatory compounds that target and inhibit the py'binding site of tyrosene kinase p56 lck sh2 domain
|
|
US7598255B2
(en)
|
2005-08-04 |
2009-10-06 |
Janssen Pharmaceutica Nv |
Pyrimidine compounds as serotonin receptor modulators
|
|
US9101613B2
(en)
|
2006-02-15 |
2015-08-11 |
Neurim Pharmaceuticals (1991) Ltd. |
Methods for treating neurological disease
|
|
MX2008015843A
(es)
|
2006-06-20 |
2009-01-09 |
Hoffmann La Roche |
Derivados de tetralina e indano y usos de los mismos.
|
|
US20080248511A1
(en)
|
2007-03-26 |
2008-10-09 |
Promega Corporation |
Methods to quench light from optical reactions
|
|
CA2686994A1
(en)
|
2007-05-11 |
2008-11-20 |
Mpex Pharmaceuticals, Inc. |
Polybasic bacterial efflux pump inhibitors and therapeutic uses thereof
|
|
BRPI0919920A2
(pt)
|
2008-10-22 |
2016-02-16 |
Acucela Inc |
compostos para tratamento de doenças e desordens oftálmicas
|
|
US20120283298A1
(en)
|
2009-10-16 |
2012-11-08 |
Albert Michael Crider |
Methods for treating memory impairment
|
|
EP2418196A1
(en)
|
2010-07-29 |
2012-02-15 |
IMTM GmbH |
Dual alanyl-aminopeptidase and dipeptidyl-peptidase IV inhibitors
|
|
GB201409516D0
(en)
*
|
2014-05-29 |
2014-07-16 |
Randox Lab Ltd |
Immunoassay for compounds of the NBOMe family
|
|
US10454900B2
(en)
|
2015-09-25 |
2019-10-22 |
Mcafee, Llc |
Remote authentication and passwordless password reset
|
|
WO2018094005A1
(en)
|
2016-11-16 |
2018-05-24 |
The General Hospital Corporation |
Myeloperoxidase imaging agents
|
|
EP3700935A4
(en)
|
2017-10-25 |
2021-08-04 |
University Of South Florida |
INGREDIENT-INDUCED ACTIVATION OF THE REELIN SIGNALING SYSTEM
|
|
CA3079819C
(en)
|
2017-11-06 |
2023-03-14 |
Acelot, Inc. |
Small molecule drugs and related methods for treatment of diseases related to a.beta.42 oligomer formation
|
|
WO2019099402A1
(en)
|
2017-11-14 |
2019-05-23 |
Rutgers, The State University Of New Jersey |
Therapeutic compounds and methods to treat infection
|
|
AU2018379992B2
(en)
|
2017-12-05 |
2022-07-21 |
Sunovion Pharmaceuticals Inc. |
Nonracemic mixtures and uses thereof
|
|
EP3841085B1
(en)
*
|
2018-08-22 |
2026-05-06 |
University Of Technology Sydney |
Nbome test
|
|
US12318357B2
(en)
|
2019-08-02 |
2025-06-03 |
Acelot, Inc. |
Small molecule drugs and related methods for treatment of diseases related to TDP-43, alpha-synuclein, huntingtin's protein and tau protein oligomer formation
|
|
US11660305B2
(en)
|
2019-11-19 |
2023-05-30 |
Turtle Bear Holdings, Llc |
Tryptamine compositions for enhancing neurite outgrowth
|
|
US12534425B2
(en)
|
2020-06-29 |
2026-01-27 |
Gilgamesh Pharmaceuticals, Inc. |
Phenalkylamines and methods of treating mood disorders
|
|
DK4172145T3
(da)
|
2020-06-30 |
2026-07-20 |
Reunion Neuroscience Inc |
Tryptamin-prodrugs som serotonin-receptor-aktivatorer til behandling af f.eks. depression
|
|
JP2024512796A
(ja)
|
2021-04-01 |
2024-03-19 |
テラン バイオサイエンシーズ インク． |
サイケデリック薬およびセロトニン受容体調節因子に関する方法と組成物
|
|
CA3217737A1
(en)
|
2021-05-11 |
2022-11-17 |
Jason WALLACH |
Selective, partial, and arrestin-biased 5-ht2a agonists with utility in various disorders
|
|
JP2024520832A
(ja)
|
2021-06-08 |
2024-05-24 |
エンセオジェニックス バイオサイエンシズ， インコーポレイテッド |
セロトニン受容体のジメトキシフェニルアルキルアミン活性化剤
|
|
WO2022261263A1
(en)
|
2021-06-08 |
2022-12-15 |
Gilgamesh Pharmaceuticals, Inc. |
Methods of treating neuropsychiatric disorders
|
|
MX2024007220A
(es)
|
2021-12-15 |
2024-08-27 |
Delix Therapeutics Inc |
Psicoplastogenos de pirrolidina fusionada y sus usos.
|
|
CA3242479A1
(en)
|
2021-12-27 |
2023-07-06 |
Atai Therapeutics, Inc. |
AMINOTERALINE SEROTONIN RECEPTOR ACTIVATORS
|
|
WO2024124056A1
(en)
|
2022-12-07 |
2024-06-13 |
Entheogenix Biosciences, Inc. |
Novel sulfoximine activators of serotonin receptors
|
|
EP4637736A1
(en)
|
2022-12-22 |
2025-10-29 |
ATAI Therapeutics, Inc. |
Prodrugs of dimethoxyphenylalkylamine activators of serotonin receptors
|
|
EP4637735A1
(en)
|
2022-12-22 |
2025-10-29 |
ATAI Therapeutics, Inc. |
Dimethoxyphenyl heteroaromatic alkylamine activators of serotonin receptors
|
|
WO2024192150A2
(en)
|
2023-03-16 |
2024-09-19 |
Atai Therapeutics Inc. |
3-alkylamine indole activators of serotonin receptors
|
|
US12343319B2
(en)
|
2023-05-01 |
2025-07-01 |
Atai Therapeutics, Inc. |
Compositions and methods for treatment of diseases and disorders
|